In the dawning of a new year and a new administration, healthcare investors cannot help but question as to what this will all …
Maxim analyst Jason McCarthy provides insight on Juno Therapeutics Inc (NASDAQ:JUNO) amid the hold placed on the firm’s JCAR015 ROCKET study, which arose …
Galena Biopharma Inc (NASDAQ:GALE) has announced it will have two post presentations at next week’s San Antonio Breast Cancer Symposium: “VADIS Trial: Phase …
Anavex Life Sciences Corp. (NASDAQ:AVXL) shares are on a 10% rise after biotech firm Lilly’s drug Solanezumab (“Sola”) just failed its third Phase …
In a research report issued Friday, Maxim analyst Jason Kolbert reiterated a Buy rating on shares of IntelliPharmaCeutics Intl Inc (USA) (NASDAQ :IPCI), …
In a research report released Wednesday, Maxim analyst Jason Kolbert reiterated a Buy rating on shares of Amedica Corporation (NASDAQ:AMDA), with a $5.00 price …
In a research report published Wednesday, Maxim analyst Jason McCarthy reiterated a Buy rating on shares of Juno Therapeutics Inc (NASDAQ:JUNO), while reducing …
After a third-quarter earnings release yesterday, Maxim analyst Jason Kolbert was out pounding the table on Amedica Corporation (NASDAQ:AMDA), reiterating a Buy rating …
Yesterday, Galena Biopharma Inc (NASDAQ:GALE) released third-quarter earnings and offered a clinical progress update on its pipeline. In reaction, Maxim analyst Jason McCarthy …
AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) shares are jumping nearly 5% after the biotech firm posted third-quarter results yesterday that with a pivotal clinical …
